NHF Provides 80% Coverage of Conditions Defined as Chronic Illnesses by WHO

With the National Health Fund (NHF) providing subsidy for 28 illnesses, this represents 80 per cent coverage of the conditions defined by the World Health Organization (WHO), as chronic illnesses.

Addressing the recent launch of the NHF’s expansion of health benefits, at the Spanish Court Hotel in St. Andrew, Chief Executive Officer (CEO), Everton Anderson, said the agency has made significant strides since its establishment in 2003.

“As we roll out these benefits through 549 pharmacy providers and 220 diagnostic providers right across Jamaica, the partnership is growing, and our commitment is to work with these partners and also work with the pharmaceutical suppliers and distributors to look at the most efficient ways of getting drugs to all patients, whether public or private, at the best prices,” Mr. Anderson said.

He underscored that drug prices can be unpredictable, especially with instability caused by the war in the Middle East, and “we have to tighten our partnerships with all our suppliers and our distributors to look at innovative ways of getting the best prices for Jamaica”.

The NHF now has 356,000 active beneficiaries, and Mr. Anderson reported that for the first time, they have reached $1 billion in annual expense for support of prostate cancer patients.

“It means that for the 4,860 persons who claim for that, they will be getting savings, on average, of $260,000. That is significant, and I encourage screening. The earlier we know what is wrong, the better it is, the easier it is to treat, and the cost profile in terms of what you pay is likely to be less,” he pointed out.

For her part, President-elect of the Medical Association of Jamaica (MAJ), Dr. Mindi Fitz-Henley, said the NHF has a critical role in safeguarding the health and well-being of the nation, because every day in doctors’ offices, clinics and hospitals, “we encounter patients battling chronic illnesses such as diabetes, hypertension, asthma and heart disease, to name a few”.

“These conditions do not only affect a person’s physical health; they also place a heavy financial burden on individuals and families. Without consistent treatment, these illnesses can lead to serious complications, disability and even premature death. And this is where the NHF plays a vital and life-saving role. Through its subsidised drug programme, the NHF makes essential medications more affordable and accessible to thousands of Jamaicans,” she said.

Deputy Chairman of the NHF, Michael Stern, said with the addition of new conditions for subsidised support, it means improved treatment and quality of life.

“These measures represent a practical and strategic investment in early detection, better disease management, a reduction in hospitalisation and healthcare costs. Importantly, these expansions are possible because the Fund has been managed carefully and responsibly,” Mr. Stern said.

The mission of the NHF, which is an agency under the Ministry of Health and Wellness, is to provide funding for healthcare benefits, health promotion, health projects, and pharmacy services in a sustainable, efficient, and customer-centric environment.

The overarching goal is to eliminate financial barriers to healthcare for Jamaicans.